Literature DB >> 23681113

Specific lymph node involvement in scleromyxedema: a new diagnostic entity for hypermetabolic lymphadenopathy.

Julie Delyon1, Maud Bézier, Michel Rybojad, Josette Brière, Pierre Validire, Martine Bagot, Anne Janin, Maxime Battistella.   

Abstract

Scleromyxedema is a generalized skin disease mostly associated with monoclonal gammopathy. In its chronic course, it can lead to systemic disorders related to mucin deposits in organs. We describe here specific lymph node involvement, hitherto not reported in scleromyxedema. A 68-year-old man with a 1-year history of micropapular eruption and skin sclerosis involving the neck, trunk, hands, and face was diagnosed with scleromyxedema associated with IgG kappa monoclonal gammopathy. Enlarged mediastinal lymph nodes found on thoracic X-ray and computed tomography scan were hypermetabolic on positron emission tomography. Lymph node biopsy showed partial nodal infiltration by numerous fibroblasts surrounded by mucin and collagen deposits, the same being observed on the skin biopsy. Lymph node and skin lesions both improved after intravenous immunoglobulin and corticosteroid treatment. Lymph node involvement in scleromyxedema should be considered in the etiological diagnosis of hypermetabolic, enlarged lymph nodes, especially if monoclonal gammopathy is associated.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681113     DOI: 10.1007/s00428-013-1424-2

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

1.  Scleromyxedema and dermato–neuro syndrome in a patient with multiple myeloma effectively treated with dexamethasone and bortezomib.

Authors:  Nicole M Fett; Mary B Toporcer; Josep Dalmau; Michi M Shinohara; Dan T Vogl
Journal:  Am J Hematol       Date:  2011-10       Impact factor: 10.047

Review 2.  Scleromyxedema.

Authors:  Clara-Dina Cokonis Georgakis; Gerald Falasca; Alexander Georgakis; Warren R Heymann
Journal:  Clin Dermatol       Date:  2006 Nov-Dec       Impact factor: 3.541

3.  Monoclonal gammopathies in B-cell non-Hodgkin's lymphomas.

Authors:  T Economopoulos; S Papageorgiou; V Pappa; E Papageorgiou; S Valsami; D Kalantzis; N Xiros; J Dervenoulas; S Raptis
Journal:  Leuk Res       Date:  2003-06       Impact factor: 3.156

4.  Stimulation of fibroblasts by paraprotein in scleromyxedema.

Authors:  G M White; E W Jeffes
Journal:  J Am Acad Dermatol       Date:  1989-10       Impact factor: 11.527

5.  Histiocytic necrotizing lymphadenitis in the context of systemic lupus erythematosus (SLE): Is histiocytic necrotizing lymphadenitis in SLE associated with skin lesions?

Authors:  S K Kim; M S Kang; B Y Yoon; D Y Kim; S K Cho; S C Bae; M Y Her
Journal:  Lupus       Date:  2011-05-11       Impact factor: 2.911

6.  Localized papular mucinosis with IgA nephropathy: a case report.

Authors:  Peng Wang; Hanjun Yang; Yuping Ran
Journal:  Arch Dermatol       Date:  2011-05

7.  Cutaneous mucinoses: microscopic criteria for diagnosis.

Authors:  F Rongioletti; A Rebora
Journal:  Am J Dermatopathol       Date:  2001-06       Impact factor: 1.533

8.  Scleromyxedema: possible association with seminoma.

Authors:  A Alfadley; I Al Hoqail; A Al Eisa
Journal:  J Am Acad Dermatol       Date:  2000-05       Impact factor: 11.527

9.  Normalization of skin appearance in a patient with scleromyxoedema after intensive chemotherapy for Hodgkin's disease.

Authors:  A S Alberts; E J Schulz; G Falkson; I W Simson; M A Coccia-Portugal
Journal:  Dermatologica       Date:  1989

10.  Scleromyxedema.

Authors:  A M Dinneen; C H Dicken
Journal:  J Am Acad Dermatol       Date:  1995-07       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.